GABSX
Price
$51.47
Change
-$0.18 (-0.35%)
Updated
Jul 31 closing price
Net Assets
1.86B
NAESX
Price
$141.37
Change
-$0.34 (-0.24%)
Updated
Jul 31 closing price
Net Assets
188.57B
Interact to see
Advertisement

GABSX vs NAESX

GABSX vs NAESX Comparison Chart in %
View a ticker or compare two or three
VS
GABSX vs. NAESX commentary
Aug 03, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is GABSX is a Hold and NAESX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
NAESX has more cash in the bank: 189B vs. GABSX (1.86B). NAESX pays higher dividends than GABSX: NAESX (1.10) vs GABSX (0.24). GABSX was incepted earlier than NAESX: GABSX (35 years) vs NAESX (66 years). GABSX (1.38) is less costly to investors than NAESX (0.17). NAESX is a more actively managed with annual turnover of: 17.00 vs. GABSX (1.00). NAESX has a lower initial minimum investment than GABSX: NAESX (0) vs GABSX (1000). NAESX annual gain was more profitable for investors over the last year : 22.56 vs. GABSX (16.58). NAESX return over 5 years is better than : 34.95 vs. GABSX (2.61).
GABSXNAESXGABSX / NAESX
Total Expense Ratio1.380.17812%
Annual Report Gross Expense Ratio1.380.17812%
Fund Existence35 years66 years-
Gain YTD13.92214.56396%
Front LoadN/AN/A-
Min. Initial Investment10000-
Min. Initial Investment IRAN/AN/A-
Net Assets1.86B189B1%
Annual Yield % from dividends0.241.1021%
Returns for 1 year16.5822.5674%
Returns for 3 years17.3343.3040%
Returns for 5 years2.6134.957%
Returns for 10 years5.70155.284%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
VMMSX32.150.39
+1.23%
Vanguard Emerg Mkts Sel Stk Inv
VRGWX936.977.54
+0.81%
Vanguard Russell 1000 Growth Index I
GIDWX20.040.13
+0.65%
Goldman Sachs US Eq Div and Premium R6
CAVAX18.710.04
+0.21%
SEI Catholic Values Equity F (SCVT)
RYOIX86.56-2.00
-2.26%
Rydex Biotechnology Inv